期刊文献+

洛丁新对UUO大鼠肾脏纤维化及其血液流变学的影响

Effect of Lotensin on Renal Interstitial Fibrosis and Hemorheology of Rats with UUO
下载PDF
导出
摘要 目的观察洛丁新对单侧输尿管梗阻(UUO)致肾间质纤维化大鼠的肾脏纤维化及其血液流变学的影响。方法采用单侧输尿管结扎法复制单侧输尿管梗阻致大鼠肾间质纤维化模型,随机均分为模型组和洛丁新组、假手术组[给药14天后处死,肾组织病理切片,测定高、中、低切变率下的全血黏度(WBV)、血浆粘度(PV)和红细胞压积(HCT)等血液流变学指标,同时检测血清肌酐(SCr)、尿素氮(BUN)。结果与模型组对比,洛丁新组在肾间质纤维化面积、肾功能指标SCr、BUN和血流高、中、低切变率下的全血黏度(WBV)、血浆粘度(PV)、红细胞压积(HCT)等指标显著降低,P<0.05。结论洛丁新能改善UUO肾间质纤维化大鼠的血液流变性,具有抗肾间质纤维化的作用。 Objective To observe the effect of Lotensin on renal interstitial fibrosis caused by unilateral ureteral obstruction(UUO) and Hemorheology of rats.Methods The model of renal obstruction was copied by UUO and then the rats were randomly divided into 3 groups: model group,Lotensin group and sham operation group;the rats were killed after drug administration for 14 days and the pathological section was made to the renal tissues,and such hemorheological data as WBV,PV and HCT at high,middle and low rates were detected as well as SCr and BUN.Result The size of renal interstitial fibrosis,the data of renal function and the hemorheological data in Lotensin group dropped down much more than those in model group(P〈0.05).Conclusions Lotensin can relieve renal interstitial fibrosis caused by UUO in rats by improving Hemorheology.
出处 《西南军医》 2011年第3期392-395,共4页 Journal of Military Surgeon in Southwest China
关键词 洛丁新 肾间质纤维化 血液流变学 Lotensin renal interstitial fibrosis hemorheology
  • 相关文献

参考文献9

  • 1董凤芹,蔡卫民,李红.肾纤维化发病机制的研究进展[J].国外医学(泌尿系统分册),2003,23(4):457-459. 被引量:30
  • 2Mezzano SA, Droguett MA, Burgos ME, et al. Overexpression of chemokines,fibrogenic eytokines, and myofibroblasts in human membranous nephmpathy [ J]. Kidney Int ,2000,57 (1) :147.
  • 3Wynn TA. Cellular and molecular mechanisms of fibrosis [J]. J Pathol, 2008, 214(2):199-210.
  • 4Ohishi T, Saito H, Tsusaka K, et al. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANESII [J]. Kidney Int, 2006, 21(2) : 147 -158.
  • 5谌洪俊,苏宁,陈昱江,朱春玲,李龙.阿魏酸钠对单侧输尿管梗阻大鼠肾间质纤维化的防治作用[J].中国药业,2010,19(1):8-10. 被引量:5
  • 6Narital, Goto S, Saito N, et al. Angiotensinogen gene variation and renoprotecfive efficacy of rennin - angiotensin system blockade in IgA nephropathy [ J]. Kidney Int ,2003,64(3 ) : 1050 - 105.
  • 7Peng H, Carretero OA, Vuljaj N, et al. Anglotensin - Converting En- zyme Inhibitors: A New Mechanism of Action [J] . Circulation. 2005 ; 112:2436 - 2445.
  • 8Gong R, Rifai A,Tolbert EM,et ao. Hepatocyte growth factor modulates matrix metallopro- teinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis [J], J Am Soc Nephro1,2003,14 (12) :3047.
  • 9吕小燕,孙学刚,刘强,吕志平.梗阻性肾间质纤维化大鼠血流变及微循环研究[J].时珍国医国药,2010,21(3):736-738. 被引量:5

二级参考文献59

  • 1牛建昭,姜术霞,李彧.多脏器纤维化的络病机制探讨[J].北京中医药大学学报,2004,27(6):4-6. 被引量:23
  • 2吴以岭.络病是区别于血瘀证的新研究领域[J].疑难病杂志,2006,5(3):189-190. 被引量:16
  • 3胡兴荣,崔显念,徐先早.糖尿病肾病HA、LN、PCⅢ、Ⅳ-C检测及其临床意义[J].检验医学与临床,2007,4(3):168-169. 被引量:19
  • 4Yang J, Dai C, Liu Y. Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice [ J ]. Gene Therapy (Basingstoke), 2001, 8 (19) : 1 470 - 1 479.
  • 5Radford MG, Donadio JV, Bergstral E J, et al. Predicting renal outcome in IgA nephropathy [ J ]. J Am Soc Nephrol, 1997, 8 (2) : 199 - 207.
  • 6Pedagogos E, Hewitson TD, Walker RG, et al. Myofibroblasts involvement in chronic transplant rejection [ J ]. Transplantation, 1997, 64 (8) : 1 192 - 1 197.
  • 7Crupp C, Troche I, Klass C, et al. A novel model to study renal myofi-broblasts formation in vitro [ J ]. Kidney lnt, 2001,59 (2) : 543 - 553.
  • 8Yamashita Y, Jeschke MG, Wolf SE. Differential expression of hepatocyte groeth factor in liver, kidney, lung, and spleen following bum in rats[J]. Cytokine, 2000, 12(9): 1 293 -1 298.
  • 9Ueda T, Takeyama Y, Hori Y, et al. Hepatocyte growth factor increases in injured organs and functions as an organotrophic factor in rats with experimental acute pancreatitis[J]. Pancreas, 2000, 20(1): 84 -93.
  • 10Liu Y, Rajur K, Tolbert E,et al. Endogenous hepatoeyte growth factor ameliorates chronic renal jijury by activating matrix degradation path- ways[J]. Kidney Int, 2000, 58(5) :2 028 - 2 043.

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部